Latest news from key diabetes conference covering the latest in medtech, treatments, research and 'cures'.
News that the National Institutes of Health halted the grant for the Diabetes Prevention Program last week, though no reason has been given.
Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.
Abbott announce that FreeStyle Libre 3 sensors will be phased out in the UK by the end of 2025 and users will need to move to FreeStyle Libre 3 Plus.
A new CGM launches this February in the UK.
Details of insulins being discontinued and availability shortages.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
Research suggesting sparkling water could lower blood glucose levels in published in the BMJ Nutrition Prevention & Health.
Abbott announce Lingo to get full rollout in US in 2025.
Save the Date for Talking About Diabetes (TAD) Event 2025.
Sana Biotechnology announce a significant step in the use of islet cells for T1D treatment that could pave the way to a T1D 'cure'!
